The European Medicines Verification Organization (EMVO) has launched a newsletter, which informs about the National Medicines Verification Organization (NMVO) and the European Change Control Board (EU CCB) created by the EMVO, various working groups – IT, quality, as well as the Inter-Operability Testing group, which allows for more efficient management of the medicines verification system and improvement of its development in all Member States.
It became clear early in the implementation of the European Medicines Verification System (EMVS) that an integrated way would be needed to manage the EMVS as a complete system and not as a collection of individual parts. The set of change management processes established within the framework of the EU CCB is constantly improved and refined.
Together with the EU CCB, several working groups have also been established to help manage the verification system and promote its development. For example, the IT Group coordinates IT compliance, technical and development issues and ensures that all parties involved properly analyse any proposal for EMVS changes.
The Quality Group, on the other hand, aims to provide an updated set of standard operating procedures (SOPs), policies and work instructions at national and system-wide levels.
Inter-Operability Testing (IOT) Group consists of 20 representatives from 3 customer groups – EMVO, Solidsoft Customer Group and Arvato Customer Group, ensuring constant coordination of development processes.
EMVO newsletter:
EMVS Community Newsletter August 2022